Bombay High Court protects ‘MEFTAL‑SPAS’ trademark
The Court found a Gorakhpur firm’s medicine deceptively similar to Blue Cross’ MEFTAL‑SPAS painkiller, granting permanent injunction and ₹10 lakh costs.
The Court found a Gorakhpur firm’s medicine deceptively similar to Blue Cross’ MEFTAL‑SPAS painkiller, granting permanent injunction and ₹10 lakh costs.